PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity
暂无分享,去创建一个
N. Holland | B. Eskenazi | A. Bradman | C. Furlong | R. Richter | Alan Ho
[1] D. Barr,et al. Organophosphate Urinary Metabolite Levels during Pregnancy and after Delivery in Women Living in an Agricultural Community , 2005, Environmental health perspectives.
[2] R. Sunahara,et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M , 2005, Journal of Lipid Research.
[3] M. Hinman,et al. Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat. , 2005, Toxicology and applied pharmacology.
[4] S. Wallenstein,et al. Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes , 2005, Nucleic acids research.
[5] T. Slotkin,et al. Developmental neurotoxicity of chlorpyrifos: targeting glial cells. , 2005, Environmental toxicology and pharmacology.
[6] Jessica G. Young,et al. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. , 2005, Neurotoxicology.
[7] M. Mackness,et al. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? , 2004, Free radical biology & medicine.
[8] N. Jewell,et al. Association of in Utero Organophosphate Pesticide Exposure and Fetal Growth and Length of Gestation in an Agricultural Population , 2004, Environmental health perspectives.
[9] G. Jarvik,et al. Determination of Paraoxonase 1 Status and Genotypes at Specific Polymorphic Sites , 2004, Current protocols in toxicology.
[10] E. Birman-Deych,et al. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. , 2003, Environmental health perspectives.
[11] R. Jackson,et al. Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. , 2003, Environmental health perspectives.
[12] D. Barr,et al. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. , 2003, Environmental health perspectives.
[13] Asa Bradman,et al. Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: a case study from the CHAMACOS cohort. , 2003, Environmental health perspectives.
[14] R. Pannbacker. Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects , 2003 .
[15] A. Tward,et al. Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.
[16] S. Deakin,et al. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor. , 2003, The Biochemical journal.
[17] Jia Chen,et al. Increased influence of genetic variation on PON1 activity in neonates. , 2003, Environmental health perspectives.
[18] C. Carlson,et al. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. , 2003, Pharmacogenetics.
[19] F. Perera,et al. Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. , 2002, Environmental health perspectives.
[20] P. Landrigan,et al. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. , 2002, Environmental health perspectives.
[21] N. Holland,et al. CHAMACOS, A Longitudinal Birth Cohort Study: Lessons from the Fields , 2003 .
[22] Richard A Fenske,et al. Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. , 2002, Environmental health perspectives.
[23] P. Durrington,et al. Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[24] G. Jarvik,et al. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. , 2001, American journal of human genetics.
[25] S. Deakin,et al. Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. , 2001, Journal of lipid research.
[26] A. Tward,et al. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. , 2000, Pharmacogenetics.
[27] G. Schellenberg,et al. Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[28] Y. Ikeda,et al. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. , 2000, Atherosclerosis.
[29] C. Pope,et al. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[30] Sheets Lp. A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides. , 2000 .
[31] V. Moser,et al. Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos. , 2000, Neurotoxicology.
[32] L. Sheets. A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides. , 2000, Neurotoxicology.
[33] G. Schellenberg,et al. Paraoxonase ( PON 1 ) Phenotype Is a Better Predictor of Vascular Disease Than Is PON 1 192 or PON 1 55 Genotype , 2000 .
[34] C. Furlong,et al. Determination of paraoxonase (PON1) status requires more than genotyping. , 1999, Pharmacogenetics.
[35] R. Fenske,et al. Farmworker exposure to organophosphorus pesticide residues during apple thinning in central Washington State. , 1999, American Industrial Hygiene Association journal.
[36] B. La Du,et al. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[37] B. Eskenazi,et al. Exposures of children to organophosphate pesticides and their potential adverse health effects. , 1999, Environmental health perspectives.
[38] V. Moser,et al. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[39] D. Shih,et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.
[40] V. Moser,et al. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. , 1998, Toxicology and applied pharmacology.
[41] R. Fenske,et al. Biological monitoring of organophosphorus pesticide exposure among children of agricultural workers in central Washington State. , 1997, Environmental health perspectives.
[42] R. Fenske,et al. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring. , 1997, Journal of toxicology and environmental health.
[43] C. Disteche,et al. Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. , 1997, Pharmacogenetics (London).
[44] J. Maurissen. Organophosphate pesticides--neurological and respiratory toxicity. , 1997, Toxicology and industrial health.
[45] M. Keifer,et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin , 1996, Nature Genetics.
[46] R H Hill,et al. Pesticide residues in urine of adults living in the United States: reference range concentrations. , 1995, Environmental research.
[47] T. Satoh,et al. Interindividual variation in carboxylesterase levels in human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[48] L. Costa,et al. Paraoxonase protects against chlorpyrifos toxicity in mice. , 1995, Toxicology letters.
[49] M. Abou‐Donia,et al. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. , 1995, Neurotoxicology.
[50] C. Abbott,et al. Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. , 1994, The Biochemical journal.
[51] L. Costa,et al. Serum paraoxonase status: a major factor in determining resistance to organophosphates. , 1993, Journal of toxicology and environmental health.
[52] D. Adler,et al. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. , 1993, Chemico-biological interactions.
[53] S. Adkins,et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.
[54] D. Adler,et al. The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.
[55] R. Humbert,et al. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. , 1991, Biochemistry.
[56] C. Pope,et al. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. , 1991, Toxicology.
[57] G. Omenn,et al. Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. , 1990, Toxicology and applied pharmacology.
[58] A. Motulsky,et al. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. , 1989, Analytical biochemistry.
[59] A. Motulsky,et al. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. , 1983, American journal of human genetics.
[60] E. Michielin,et al. Characteristics and behaviour of arylesterase in human serum and liver , 1977, European journal of clinical investigation.
[61] D. S. Stephens,et al. Perinatal development of human blood esterases , 1973, Clinical pharmacology and therapeutics.
[62] K. Augustinsson,et al. AGE VARIATION IN PLASMA ARYLESTERASE ACTIVITY IN CHILDREN. , 1963, Clinica chimica acta; international journal of clinical chemistry.
[63] A. Main. The role of A-esterase in the acute toxicity of paraoxon, TEPP, and parathion. , 1956, Canadian journal of biochemistry and physiology.